clinical trial · NCT06307522
MRG-001 in Patients With Alcoholic Hepatitis
Alcoholic HepatitisAcute Alcoholic HepatitisMRG-001
brief summary
The goal of this study is to test MRG-001 (an experimental medication). The purpose of this trial is to assess the dose related safety, Pharmacokinetics, and Pharmacodynamics of MRG-001 in patients with severe alcoholic hepatitis (AH).
started
Sep 1, 2024
primary completion
Sep 1, 2026
completion
Dec 1, 2026
last updated
Mar 13, 2024
official title
An Open-Label, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of MRG-001 in Patients With Alcoholic Hepatitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol